nodes	percent_of_prediction	percent_of_DWPC	metapath
Valganciclovir—Pneumocystis jirovecii pneumonia—Thalidomide—leprosy	0.0629	0.0629	CcSEcCtD
Valganciclovir—Cholangitis—Thalidomide—leprosy	0.0455	0.0455	CcSEcCtD
Valganciclovir—Creatinine low—Thalidomide—leprosy	0.0412	0.0412	CcSEcCtD
Valganciclovir—Blood creatinine decreased—Thalidomide—leprosy	0.0377	0.0377	CcSEcCtD
Valganciclovir—Hypoproteinaemia—Thalidomide—leprosy	0.0269	0.0269	CcSEcCtD
Valganciclovir—Ascites—Thalidomide—leprosy	0.0174	0.0174	CcSEcCtD
Valganciclovir—Lactic dehydrogenase activity increased—Thalidomide—leprosy	0.0154	0.0154	CcSEcCtD
Valganciclovir—Blood lactate dehydrogenase increased—Thalidomide—leprosy	0.0136	0.0136	CcSEcCtD
Valganciclovir—Serum creatinine increased—Thalidomide—leprosy	0.0128	0.0128	CcSEcCtD
Valganciclovir—Hypomagnesaemia—Thalidomide—leprosy	0.0124	0.0124	CcSEcCtD
Valganciclovir—Oral candidiasis—Thalidomide—leprosy	0.0124	0.0124	CcSEcCtD
Valganciclovir—Psychotic disorder—Dapsone—leprosy	0.0109	0.0109	CcSEcCtD
Valganciclovir—Pleural effusion—Thalidomide—leprosy	0.0103	0.0103	CcSEcCtD
Valganciclovir—Amblyopia—Thalidomide—leprosy	0.0102	0.0102	CcSEcCtD
Valganciclovir—Nasopharyngitis—Dapsone—leprosy	0.01	0.01	CcSEcCtD
Valganciclovir—Influenza—Dapsone—leprosy	0.00967	0.00967	CcSEcCtD
Valganciclovir—Pancreatitis—Dapsone—leprosy	0.00948	0.00948	CcSEcCtD
Valganciclovir—Blood disorder—Thalidomide—leprosy	0.00945	0.00945	CcSEcCtD
Valganciclovir—Acne—Thalidomide—leprosy	0.00938	0.00938	CcSEcCtD
Valganciclovir—Photosensitivity reaction—Dapsone—leprosy	0.00883	0.00883	CcSEcCtD
Valganciclovir—Viral infection—Thalidomide—leprosy	0.00874	0.00874	CcSEcCtD
Valganciclovir—Thinking abnormal—Thalidomide—leprosy	0.00862	0.00862	CcSEcCtD
Valganciclovir—Hypocalcaemia—Thalidomide—leprosy	0.00862	0.00862	CcSEcCtD
Valganciclovir—Neuropathy peripheral—Dapsone—leprosy	0.00845	0.00845	CcSEcCtD
Valganciclovir—Leukocytosis—Thalidomide—leprosy	0.0084	0.0084	CcSEcCtD
Valganciclovir—Sinusitis—Dapsone—leprosy	0.00809	0.00809	CcSEcCtD
Valganciclovir—Hyperkalaemia—Thalidomide—leprosy	0.00775	0.00775	CcSEcCtD
Valganciclovir—Eructation—Thalidomide—leprosy	0.00775	0.00775	CcSEcCtD
Valganciclovir—Pharyngitis—Dapsone—leprosy	0.00768	0.00768	CcSEcCtD
Valganciclovir—Candida infection—Thalidomide—leprosy	0.00754	0.00754	CcSEcCtD
Valganciclovir—Aplastic anaemia—Thalidomide—leprosy	0.00741	0.00741	CcSEcCtD
Valganciclovir—Tinnitus—Dapsone—leprosy	0.00722	0.00722	CcSEcCtD
Valganciclovir—Oesophagitis—Thalidomide—leprosy	0.00721	0.00721	CcSEcCtD
Valganciclovir—Hypertonia—Thalidomide—leprosy	0.00692	0.00692	CcSEcCtD
Valganciclovir—Sepsis—Thalidomide—leprosy	0.00685	0.00685	CcSEcCtD
Valganciclovir—Mental disability—Thalidomide—leprosy	0.00685	0.00685	CcSEcCtD
Valganciclovir—Lymphadenopathy—Thalidomide—leprosy	0.00672	0.00672	CcSEcCtD
Valganciclovir—Thrombophlebitis—Thalidomide—leprosy	0.00662	0.00662	CcSEcCtD
Valganciclovir—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.00659	0.00659	CcSEcCtD
Valganciclovir—Diabetes mellitus—Thalidomide—leprosy	0.00659	0.00659	CcSEcCtD
Valganciclovir—Deafness—Thalidomide—leprosy	0.0064	0.0064	CcSEcCtD
Valganciclovir—Vision blurred—Dapsone—leprosy	0.00635	0.00635	CcSEcCtD
Valganciclovir—Eye pain—Thalidomide—leprosy	0.00635	0.00635	CcSEcCtD
Valganciclovir—Libido decreased—Thalidomide—leprosy	0.00618	0.00618	CcSEcCtD
Valganciclovir—Amnesia—Thalidomide—leprosy	0.0061	0.0061	CcSEcCtD
Valganciclovir—Dermatitis exfoliative—Thalidomide—leprosy	0.00607	0.00607	CcSEcCtD
Valganciclovir—Vertigo—Dapsone—leprosy	0.00606	0.00606	CcSEcCtD
Valganciclovir—Cough—Dapsone—leprosy	0.00588	0.00588	CcSEcCtD
Valganciclovir—Pain in extremity—Thalidomide—leprosy	0.00573	0.00573	CcSEcCtD
Valganciclovir—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00573	0.00573	CcSEcCtD
Valganciclovir—Disturbance in sexual arousal—Thalidomide—leprosy	0.00568	0.00568	CcSEcCtD
Valganciclovir—Migraine—Thalidomide—leprosy	0.00564	0.00564	CcSEcCtD
Valganciclovir—Psychotic disorder—Thalidomide—leprosy	0.0056	0.0056	CcSEcCtD
Valganciclovir—Ataxia—Thalidomide—leprosy	0.00539	0.00539	CcSEcCtD
Valganciclovir—Tachycardia—Dapsone—leprosy	0.00537	0.00537	CcSEcCtD
Valganciclovir—Blood creatinine increased—Thalidomide—leprosy	0.00537	0.00537	CcSEcCtD
Valganciclovir—Dehydration—Thalidomide—leprosy	0.00533	0.00533	CcSEcCtD
Valganciclovir—Dry skin—Thalidomide—leprosy	0.00525	0.00525	CcSEcCtD
Valganciclovir—Hypokalaemia—Thalidomide—leprosy	0.00521	0.00521	CcSEcCtD
Valganciclovir—Cramp muscle—Thalidomide—leprosy	0.00516	0.00516	CcSEcCtD
Valganciclovir—Abdominal distension—Thalidomide—leprosy	0.00498	0.00498	CcSEcCtD
Valganciclovir—Insomnia—Dapsone—leprosy	0.00498	0.00498	CcSEcCtD
Valganciclovir—Influenza—Thalidomide—leprosy	0.00495	0.00495	CcSEcCtD
Valganciclovir—Dysphagia—Thalidomide—leprosy	0.00495	0.00495	CcSEcCtD
Valganciclovir—Eosinophilia—Thalidomide—leprosy	0.0049	0.0049	CcSEcCtD
Valganciclovir—Pancreatitis—Thalidomide—leprosy	0.00485	0.00485	CcSEcCtD
Valganciclovir—Bronchitis—Thalidomide—leprosy	0.00476	0.00476	CcSEcCtD
Valganciclovir—Pancytopenia—Thalidomide—leprosy	0.0047	0.0047	CcSEcCtD
Valganciclovir—Neutropenia—Thalidomide—leprosy	0.00463	0.00463	CcSEcCtD
Valganciclovir—Upper respiratory tract infection—Thalidomide—leprosy	0.0046	0.0046	CcSEcCtD
Valganciclovir—Pollakiuria—Thalidomide—leprosy	0.00457	0.00457	CcSEcCtD
Valganciclovir—Erectile dysfunction—Thalidomide—leprosy	0.00456	0.00456	CcSEcCtD
Valganciclovir—Photosensitivity reaction—Thalidomide—leprosy	0.00452	0.00452	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Dapsone—leprosy	0.0045	0.0045	CcSEcCtD
Valganciclovir—Weight decreased—Thalidomide—leprosy	0.00448	0.00448	CcSEcCtD
Valganciclovir—Hyperglycaemia—Thalidomide—leprosy	0.00447	0.00447	CcSEcCtD
Valganciclovir—Pneumonia—Thalidomide—leprosy	0.00444	0.00444	CcSEcCtD
Valganciclovir—Infestation—Thalidomide—leprosy	0.00442	0.00442	CcSEcCtD
Valganciclovir—Infestation NOS—Thalidomide—leprosy	0.00442	0.00442	CcSEcCtD
Valganciclovir—Depression—Thalidomide—leprosy	0.0044	0.0044	CcSEcCtD
Valganciclovir—Abdominal pain—Dapsone—leprosy	0.00435	0.00435	CcSEcCtD
Valganciclovir—Body temperature increased—Dapsone—leprosy	0.00435	0.00435	CcSEcCtD
Valganciclovir—Renal failure—Thalidomide—leprosy	0.00434	0.00434	CcSEcCtD
Valganciclovir—Neuropathy peripheral—Thalidomide—leprosy	0.00433	0.00433	CcSEcCtD
Valganciclovir—Stomatitis—Thalidomide—leprosy	0.0043	0.0043	CcSEcCtD
Valganciclovir—Haematuria—Thalidomide—leprosy	0.00421	0.00421	CcSEcCtD
Valganciclovir—Sinusitis—Thalidomide—leprosy	0.00414	0.00414	CcSEcCtD
Valganciclovir—Hepatitis—Thalidomide—leprosy	0.00396	0.00396	CcSEcCtD
Valganciclovir—Pharyngitis—Thalidomide—leprosy	0.00393	0.00393	CcSEcCtD
Valganciclovir—Urinary tract disorder—Thalidomide—leprosy	0.00391	0.00391	CcSEcCtD
Valganciclovir—Oedema peripheral—Thalidomide—leprosy	0.0039	0.0039	CcSEcCtD
Valganciclovir—Urethral disorder—Thalidomide—leprosy	0.00389	0.00389	CcSEcCtD
Valganciclovir—Visual impairment—Thalidomide—leprosy	0.00382	0.00382	CcSEcCtD
Valganciclovir—Eye disorder—Thalidomide—leprosy	0.0037	0.0037	CcSEcCtD
Valganciclovir—Tinnitus—Thalidomide—leprosy	0.0037	0.0037	CcSEcCtD
Valganciclovir—Cardiac disorder—Thalidomide—leprosy	0.00368	0.00368	CcSEcCtD
Valganciclovir—Angiopathy—Thalidomide—leprosy	0.0036	0.0036	CcSEcCtD
Valganciclovir—Immune system disorder—Thalidomide—leprosy	0.00358	0.00358	CcSEcCtD
Valganciclovir—Mediastinal disorder—Thalidomide—leprosy	0.00357	0.00357	CcSEcCtD
Valganciclovir—Chills—Thalidomide—leprosy	0.00356	0.00356	CcSEcCtD
Valganciclovir—Arrhythmia—Thalidomide—leprosy	0.00354	0.00354	CcSEcCtD
Valganciclovir—Alopecia—Thalidomide—leprosy	0.0035	0.0035	CcSEcCtD
Valganciclovir—Vomiting—Dapsone—leprosy	0.0035	0.0035	CcSEcCtD
Valganciclovir—Mental disorder—Thalidomide—leprosy	0.00347	0.00347	CcSEcCtD
Valganciclovir—Malnutrition—Thalidomide—leprosy	0.00345	0.00345	CcSEcCtD
Valganciclovir—Headache—Dapsone—leprosy	0.00345	0.00345	CcSEcCtD
Valganciclovir—Flatulence—Thalidomide—leprosy	0.0034	0.0034	CcSEcCtD
Valganciclovir—Tension—Thalidomide—leprosy	0.00339	0.00339	CcSEcCtD
Valganciclovir—Dysgeusia—Thalidomide—leprosy	0.00338	0.00338	CcSEcCtD
Valganciclovir—Nervousness—Thalidomide—leprosy	0.00335	0.00335	CcSEcCtD
Valganciclovir—Back pain—Thalidomide—leprosy	0.00334	0.00334	CcSEcCtD
Valganciclovir—Muscle spasms—Thalidomide—leprosy	0.00332	0.00332	CcSEcCtD
Valganciclovir—Nausea—Dapsone—leprosy	0.00327	0.00327	CcSEcCtD
Valganciclovir—Vision blurred—Thalidomide—leprosy	0.00325	0.00325	CcSEcCtD
Valganciclovir—Tremor—Thalidomide—leprosy	0.00323	0.00323	CcSEcCtD
Valganciclovir—Ill-defined disorder—Thalidomide—leprosy	0.0032	0.0032	CcSEcCtD
Valganciclovir—Anaemia—Thalidomide—leprosy	0.00319	0.00319	CcSEcCtD
Valganciclovir—Agitation—Thalidomide—leprosy	0.00317	0.00317	CcSEcCtD
Valganciclovir—Malaise—Thalidomide—leprosy	0.00311	0.00311	CcSEcCtD
Valganciclovir—Vertigo—Thalidomide—leprosy	0.0031	0.0031	CcSEcCtD
Valganciclovir—Leukopenia—Thalidomide—leprosy	0.00309	0.00309	CcSEcCtD
Valganciclovir—Cough—Thalidomide—leprosy	0.00301	0.00301	CcSEcCtD
Valganciclovir—Convulsion—Thalidomide—leprosy	0.00299	0.00299	CcSEcCtD
Valganciclovir—Hypertension—Thalidomide—leprosy	0.00298	0.00298	CcSEcCtD
Valganciclovir—Arthralgia—Thalidomide—leprosy	0.00294	0.00294	CcSEcCtD
Valganciclovir—Anxiety—Thalidomide—leprosy	0.00293	0.00293	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00292	0.00292	CcSEcCtD
Valganciclovir—Discomfort—Thalidomide—leprosy	0.0029	0.0029	CcSEcCtD
Valganciclovir—Dry mouth—Thalidomide—leprosy	0.00287	0.00287	CcSEcCtD
Valganciclovir—Confusional state—Thalidomide—leprosy	0.00284	0.00284	CcSEcCtD
Valganciclovir—Oedema—Thalidomide—leprosy	0.00282	0.00282	CcSEcCtD
Valganciclovir—Infection—Thalidomide—leprosy	0.0028	0.0028	CcSEcCtD
Valganciclovir—Nervous system disorder—Thalidomide—leprosy	0.00276	0.00276	CcSEcCtD
Valganciclovir—Thrombocytopenia—Thalidomide—leprosy	0.00276	0.00276	CcSEcCtD
Valganciclovir—Tachycardia—Thalidomide—leprosy	0.00275	0.00275	CcSEcCtD
Valganciclovir—Skin disorder—Thalidomide—leprosy	0.00274	0.00274	CcSEcCtD
Valganciclovir—Hyperhidrosis—Thalidomide—leprosy	0.00272	0.00272	CcSEcCtD
Valganciclovir—Anorexia—Thalidomide—leprosy	0.00268	0.00268	CcSEcCtD
Valganciclovir—Hypotension—Thalidomide—leprosy	0.00263	0.00263	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Thalidomide—leprosy	0.00257	0.00257	CcSEcCtD
Valganciclovir—Insomnia—Thalidomide—leprosy	0.00255	0.00255	CcSEcCtD
Valganciclovir—Paraesthesia—Thalidomide—leprosy	0.00253	0.00253	CcSEcCtD
Valganciclovir—Dyspnoea—Thalidomide—leprosy	0.00251	0.00251	CcSEcCtD
Valganciclovir—Somnolence—Thalidomide—leprosy	0.0025	0.0025	CcSEcCtD
Valganciclovir—Dyspepsia—Thalidomide—leprosy	0.00248	0.00248	CcSEcCtD
Valganciclovir—Decreased appetite—Thalidomide—leprosy	0.00245	0.00245	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Thalidomide—leprosy	0.00243	0.00243	CcSEcCtD
Valganciclovir—Fatigue—Thalidomide—leprosy	0.00243	0.00243	CcSEcCtD
Valganciclovir—Pain—Thalidomide—leprosy	0.00241	0.00241	CcSEcCtD
Valganciclovir—Constipation—Thalidomide—leprosy	0.00241	0.00241	CcSEcCtD
Valganciclovir—Feeling abnormal—Thalidomide—leprosy	0.00232	0.00232	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Thalidomide—leprosy	0.0023	0.0023	CcSEcCtD
Valganciclovir—Urticaria—Thalidomide—leprosy	0.00224	0.00224	CcSEcCtD
Valganciclovir—Abdominal pain—Thalidomide—leprosy	0.00223	0.00223	CcSEcCtD
Valganciclovir—Body temperature increased—Thalidomide—leprosy	0.00223	0.00223	CcSEcCtD
Valganciclovir—Hypersensitivity—Thalidomide—leprosy	0.00207	0.00207	CcSEcCtD
Valganciclovir—Asthenia—Thalidomide—leprosy	0.00202	0.00202	CcSEcCtD
Valganciclovir—Pruritus—Thalidomide—leprosy	0.00199	0.00199	CcSEcCtD
Valganciclovir—Diarrhoea—Thalidomide—leprosy	0.00193	0.00193	CcSEcCtD
Valganciclovir—Dizziness—Thalidomide—leprosy	0.00186	0.00186	CcSEcCtD
Valganciclovir—Vomiting—Thalidomide—leprosy	0.00179	0.00179	CcSEcCtD
Valganciclovir—Dermatitis—Thalidomide—leprosy	0.00177	0.00177	CcSEcCtD
Valganciclovir—Headache—Thalidomide—leprosy	0.00176	0.00176	CcSEcCtD
Valganciclovir—Nausea—Thalidomide—leprosy	0.00167	0.00167	CcSEcCtD
